| Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis K Brandl, P Hartmann, LJ Jih, DP Pizzo, J Argemi, M Ventura-Cots, ... Journal of hepatology 69 (2), 396-405, 2018 | 167 | 2018 |
| Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis J Argemi, MU Latasa, SR Atkinson, IO Blokhin, V Massey, JP Gue, ... Nature communications 10 (1), 3126, 2019 | 162 | 2019 |
| Alcohol-related liver disease is rarely detected at early stages compared with liver diseases of other etiologies worldwide ND Shah, M Ventura-Cots, JG Abraldes, M Alboraie, A Alfadhli, J Argemi, ... Clinical Gastroenterology and Hepatology 17 (11), 2320-2329. e12, 2019 | 113 | 2019 |
| A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets J Bayo, EJ Fiore, LM Dominguez, A Real, M Malvicini, M Rizzo, ... Journal of hepatology 71 (1), 78-90, 2019 | 94 | 2019 |
| Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values A Fernandez-Montero, J Argemi, JA Rodríguez, AH Arino, ... EClinicalMedicine 37, 2021 | 89 | 2021 |
| Chronic hepatitis B in pregnancy: unique challenges and opportunities K Yogeswaran, SK Fung The Korean journal of hepatology 17 (1), 1, 2011 | 83 | 2011 |
| Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation D Castaño, E Larequi, I Belza, AM Astudillo, E Martínez-Ansó, J Balsinde, ... Journal of hepatology 60 (5), 1017-1025, 2014 | 72 | 2014 |
| Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation J Luther, S Khan, MK Gala, D Kedrin, G Sridharan, RP Goodman, ... Proceedings of the National Academy of Sciences 117 (21), 11667-11673, 2020 | 62 | 2020 |
| Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis M Liu, S Cao, L He, J Gao, JP Arab, H Cui, W Xuan, Y Gao, TS Sehrawat, ... Nature communications 12 (1), 4560, 2021 | 60 | 2021 |
| Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis DW Kurniawan, AK Jajoriya, G Dhawan, D Mishra, J Argemi, R Bataller, ... Journal of controlled release 288, 227-238, 2018 | 53 | 2018 |
| The MELD score is superior to the Maddrey discriminant function score to predict short-term mortality in alcohol-associated hepatitis: a global study D Morales-Arráez, M Ventura-Cots, J Altamirano, JG Abraldes, ... Official journal of the American College of Gastroenterology| ACG 117 (2 …, 2022 | 52 | 2022 |
| Iron affects Ire1 clustering propensity and the amplitude of endoplasmic reticulum stress signaling N Cohen, M Breker, A Bakunts, K Pesek, A Chas, J Argemi, A Orsi, L Gal, ... Journal of cell science 130 (19), 3222-3233, 2017 | 52 | 2017 |
| Assessing the impact of COVID-19 on liver cancer management (CERO-19) S Muñoz-Martínez, V Sapena, A Forner, JC Nault, G Sapisochin, ... JHEP reports 3 (3), 100260, 2021 | 50 | 2021 |
| ACOX2 deficiency: an inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia MJ Monte, M Alonso-Peña, O Briz, E Herraez, C Berasain, J Argemi, ... Journal of hepatology 66 (3), 581-588, 2017 | 49 | 2017 |
| X-box binding protein 1 regulates unfolded protein, acute-phase, and DNA damage responses during regeneration of mouse liver J Argemí, TR Kress, HCY Chang, R Ferrero, C Bértolo, H Moreno, ... Gastroenterology 152 (5), 1203-1216. e15, 2017 | 47 | 2017 |
| Loss of liver function in chronic liver disease: An identity crisis C Berasain, M Arechederra, J Argemí, MG Fernández-Barrena, MA Avila Journal of hepatology 78 (2), 401-414, 2023 | 42 | 2023 |
| Integrated multiomics reveals glucose use reprogramming and identifies a novel hexokinase in alcoholic hepatitis V Massey, A Parrish, J Argemi, M Moreno, A Mello, M García-Rocha, ... Gastroenterology 160 (5), 1725-1740. e2, 2021 | 42 | 2021 |
| Loss of hepatocyte identity following aberrant YAP activation: a key mechanism in alcoholic hepatitis MB Saleh, A Louvet, LC Ntandja-Wandji, E Boleslawski, V Gnemmi, ... Journal of hepatology 75 (4), 912-923, 2021 | 41 | 2021 |
| Inhibition of HSP90 and activation of HSF1 diminish macrophage NLRP3 inflammasome activity in alcohol‐associated liver injury A Choudhury, D Bullock, A Lim, J Argemi, P Orning, E Lien, R Bataller, ... Alcoholism: Clinical and Experimental Research 44 (6), 1300-1311, 2020 | 40 | 2020 |
| Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension J Chen, J Argemi, G Odena, MJ Xu, Y Cai, V Massey, A Parrish, ... Scientific reports 10 (1), 15558, 2020 | 36 | 2020 |
